Streetbeat News

Regulatory

EVLV

Evolv Technology has announced that shareholders and others should not rely on certain previously issued financial statements. The company will delay filing its quarterly report.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:01 pm

EVLV

Trading for a company has been halted at 7:55:00 a.m. ET due to pending news. This could indicate significant upcoming announcements that may impact the stock price.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:55 am

ICE

The New York Stock Exchange (NYSE) plans to extend trading hours on its NYSE Arca Equities Exchange to 22 hours a day. The extended-hours trades will be cleared by the Depository Trust & Clearing Corporation (DTCC).

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:32 am

PPBT

Purple Biotech has presented new data on its tri-specific antibody platform, CAPTN-3, with the lead compound IM1240 targeting solid tumors. The company aims to reach first human clinical studies by 2026.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:23 am

GOOG

GOOGL

Waymo, a subsidiary of Alphabet Inc., reported that its driverless fleet has driven 25 million miles, claiming a safer record than human drivers. Despite this, the NHTSA is investigating Waymo for safety concerns, including unexpected driving behaviors and traffic rule violations.

Portfolio Pulse from Anan Ashraf

October 25, 2024 | 11:22 am

SVCO

Silvaco has achieved ISO 9001 certification for its suite of TCAD, EDA, and IP products, indicating a commitment to quality management standards.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:06 am

EDBL

Edible Garden has received USDA grants to support research and development for organic certification at its facilities in Belvidere, New Jersey, and Grand Rapids, Michigan.

Portfolio Pulse from Nabaparna Bhattacharya

October 25, 2024 | 11:04 am

ANIP

ANI Pharmaceuticals has received final approval from the U.S. FDA for its Abbreviated New Drug Application and launched Estradiol Gel, 0.06%, a generic version of Estrogel Gel, 0.06%.

Portfolio Pulse from Nabaparna Bhattacharya

October 25, 2024 | 10:53 am

ZYME

Zymeworks has released new preclinical data for its antibody-drug conjugate candidates, ZW220 and ZW251. These findings support the submission of Investigational New Drug applications.

Portfolio Pulse from Nabaparna Bhattacharya

October 25, 2024 | 10:07 am

AAPL

AMZN

BELT

FBGRX

META

MSFT

NVDA

TSLA

Major U.S. investment funds are selling shares to comply with IRS tax regulations due to a tech-driven stock market surge. This affects funds like Fidelity and T Rowe Price, as tech giants like Nvidia, Apple, Meta, Microsoft, and Amazon account for a significant portion of market gains.

Portfolio Pulse from Benzinga Neuro

October 25, 2024 | 8:33 am